Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

CONCLUSIONS: The BP lowering effect of endovascular ultrasound RDN was maintained at 6 months with less prescribed antihypertensive medications compared with a sham control. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov Unique Identifier: NCT02649426. PMID: 30880441 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30880441?dopt=Abstract

Source: Circulation - March 16, 2019 Category: Cardiology Authors: Azizi M, Schmieder RE, Mahfoud F, Weber M, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile JN, Wang Y, Saxena M, Lurz P, Rader F, Sayer JW, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, J Kirtane A Tags: Circulation Source Type: research